Sep. 24, 2009 (PR Newswire) --
MELVILLE, N.Y., Sept. 24 /PRNewswire-FirstCall/ -- Henry Schein, Inc. (Nasdaq: HSIC), the largest distributor of healthcare products and services to office-based practitioners, today announced the appointment of Lonnie Shoff to the newly-created position of President, Henry Schein Global Healthcare Specialties Group. In her new position, Ms. Shoff will join the Company's Executive Management Committee and report to Henry Schein Chairman and Chief Executive Officer, Stanley M. Bergman.
(Photo: http://www.newscom.com/cgi-bin/prnh/20090924/NY81301 )
"Lonnie's proven leadership skills will help drive our Company's future growth by increasing our focus on the pursuit of businesses that complement our North American and International Groups," said Mr. Bergman. "Lonnie's portfolio will include building our specialty businesses and expanding our exclusive and semi-exclusive product and service offerings. The newly-formed Henry Schein Global Healthcare Specialties Group that Lonnie will lead reflects the strong entrepreneurial spirit that has driven our Company since we were founded in 1932. It will be instrumental as we continue to transform our Company to become even more relevant to our customers around the world and help drive the success of our customers' practices."
Within the new Henry Schein Global Healthcare Specialties Group, Ms. Shoff will be responsible for Henry Schein Global Dental Specialties and Henry Schein Global Exclusive Brands. Sales from these businesses will continue to be reported as part of the Company's Dental, Medical and International Groups.
Ms. Shoff joins Henry Schein from Roche Diagnostics, where she held a series of increasingly responsible positions in the United States and Switzerland over the past 20 years, focusing on applied science, molecular diagnostics, global business development, and marketing and business management. Most recently, Ms. Shoff served as Senior Vice President & General Manager, Applied Science, leading the U.S. commercial operations for this $350 million group.
Ms. Shoff has managed the life cycles of more than 2,500 products, and nurtured ventures from seed funding through product launch. While at Roche Diagnostics, Ms. Shoff also built a Global Internal Venturing Program, which the London School of Business praised in its book, Inventuring: Why Big Companies Must Think Small. Ms. Shoff earned a bachelor's degree in Biological Sciences from Purdue University and attended graduate school for Genetics at Temple University.
About Henry Schein
Henry Schein, a Fortune 500(R) company and a member of the NASDAQ 100(R) Index, is recognized for its excellent customer service and highly competitive prices.
